BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

977 related articles for article (PubMed ID: 32895551)

  • 1. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.
    Zheng J; Haberland V; Baird D; Walker V; Haycock PC; Hurle MR; Gutteridge A; Erola P; Liu Y; Luo S; Robinson J; Richardson TG; Staley JR; Elsworth B; Burgess S; Sun BB; Danesh J; Runz H; Maranville JC; Martin HM; Yarmolinsky J; Laurin C; Holmes MV; Liu JZ; Estrada K; Santos R; McCarthy L; Waterworth D; Nelson MR; Smith GD; Butterworth AS; Hemani G; Scott RA; Gaunt TR
    Nat Genet; 2020 Oct; 52(10):1122-1131. PubMed ID: 32895551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
    Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
    Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
    Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
    J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis.
    Zou M; Shao Z
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome-Wide Mendelian Randomization Identifies Causal Links Between Blood Proteins and Acute Pancreatitis.
    Bourgault J; Abner E; Manikpurage HD; Pujol-Gualdo N; Laisk T; ; Gobeil É; Gagnon E; Girard A; Mitchell PL; Thériault S; Esko T; Mathieu P; Arsenault BJ
    Gastroenterology; 2023 May; 164(6):953-965.e3. PubMed ID: 36736436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.
    Chen J; Xu F; Ruan X; Sun J; Zhang Y; Zhang H; Zhao J; Zheng J; Larsson SC; Wang X; Li X; Yuan S
    EBioMedicine; 2023 Mar; 89():104494. PubMed ID: 36857861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome-wide analysis reveals potential therapeutic targets for Colorectal cancer: a two-sample mendelian randomization study.
    Cai YX; Wu YQ; Liu J; Pan H; Deng W; Sun W; Xie C; Huang XF
    BMC Cancer; 2023 Dec; 23(1):1188. PubMed ID: 38049731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis.
    Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J
    Front Immunol; 2024; 15():1366736. PubMed ID: 38566994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ​Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction.
    Sun Z; Yun Z; Lin J; Sun X; Wang Q; Duan J; Li C; Zhang X; Xu S; Wang Z; Xiong X; Yao K
    J Transl Med; 2024 Apr; 22(1):404. PubMed ID: 38689297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses.
    Zhang W; Ma L; Zhou Q; Gu T; Zhang X; Xing H
    Diabetes; 2024 Apr; 73(4):618-627. PubMed ID: 38211557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke.
    Chen L; Peters JE; Prins B; Persyn E; Traylor M; Surendran P; Karthikeyan S; Yonova-Doing E; Di Angelantonio E; Roberts DJ; Watkins NA; Ouwehand WH; Danesh J; Lewis CM; Bronson PG; Markus HS; Burgess S; Butterworth AS; Howson JMM
    Nat Commun; 2022 Oct; 13(1):6143. PubMed ID: 36253349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis.
    Ouyang Y; Chen Y; Chen K; Tang Z; Shi G; Qu C; Zhang K; Yang H
    Hum Genomics; 2024 Apr; 18(1):43. PubMed ID: 38659056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
    Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
    Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically Determined Chronic Low-Grade Inflammation and Hundreds of Health Outcomes in the UK Biobank and the FinnGen Population: A Phenome-Wide Mendelian Randomization Study.
    Si S; Li J; Tewara MA; Xue F
    Front Immunol; 2021; 12():720876. PubMed ID: 34386016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Causal Plasma Proteins for Hypothyroidism: A Large-scale Plasma Proteome Mendelian Randomization Analysis.
    Yang H; Chen L; Liu Y
    J Clin Endocrinol Metab; 2023 Jan; 108(2):433-442. PubMed ID: 36190832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome-Wide Mendelian Randomization Analysis Identified Potential Drug Targets for Atrial Fibrillation.
    Wang X; Huang T; Jia J
    J Am Heart Assoc; 2023 Aug; 12(16):e029003. PubMed ID: 37581400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses.
    Yuan S; Xu F; Li X; Chen J; Zheng J; Mantzoros CS; Larsson SC
    Cell Rep Med; 2023 Sep; 4(9):101174. PubMed ID: 37652020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis.
    Chen L; Zhao Y; Li M; Lv G
    Hepatol Int; 2024 Apr; 18(2):517-528. PubMed ID: 37950809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteome-wide mendelian randomization identifies causal plasma proteins in venous thromboembolism development.
    Li H; Zhang Z; Qiu Y; Weng H; Yuan S; Zhang Y; Zhang Y; Xi L; Xu F; Ji X; Hao R; Yang P; Chen G; Zuo X; Zhai Z; Wang C
    J Hum Genet; 2023 Dec; 68(12):805-812. PubMed ID: 37537391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenome-wide Mendelian randomization study of plasma triglyceride levels and 2600 disease traits.
    Park JK; Bafna S; Forrest IS; Duffy Á; Marquez-Luna C; Petrazzini BO; Vy HM; Jordan DM; Verbanck M; Narula J; Rosenson RS; Rocheleau G; Do R
    Elife; 2023 Mar; 12():. PubMed ID: 36988189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.